Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T17:06:23.576Z.
Calculation as of: 2026-10-06T17:06:23.576Z.
Quote observation: 2026-10-06T17:04:55.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 26be04fabca1f5abb96b6b094ab833c4d2e2f23bc88365d6eea621c26c981704
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Corbus Pharmaceuticals Holdings, Inc.
Market Cap
$108.20M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.05M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$107.44M
Free Cash Flow Yield
N/A
TTM Avg
13.79%
3Y Avg
13.79%
5Y Avg
13.79%
Market Cap
$106.68M
Free Cash Flow Yield
N/A
TTM Avg
10.25%
3Y Avg
16.93%
5Y Avg
15.95%
Market Cap
$110.12M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.20M
Free Cash Flow Yield
27.15%
TTM Avg
25.60%
3Y Avg
13.86%
5Y Avg
9.06%
Market Cap
$104.79M
Free Cash Flow Yield
N/A
TTM Avg
6.54%
3Y Avg
6.54%
5Y Avg
6.54%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | $108.20M | N/A | N/A | N/A | N/A |
| Outlook Therapeutics, Inc. (OTLK)vs › | $108.05M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $107.44M | N/A | 13.79% | 13.79% | 13.79% |
| Immunic, Inc. (IMUX)vs › | $107.34M | N/A | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.68M | N/A | 10.25% | 16.93% | 15.95% |
| Apyx Medical Corporation (APYX)vs › | $110.12M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $111.14M | N/A | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.20M | 27.15% | 25.60% | 13.86% | 9.06% |
| Anixa Biosciences, Inc. (ANIX)vs › | $104.79M | N/A | 6.54% | 6.54% | 6.54% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
